Zhu G, Johnson J, McDougald L R
Department of Poultry Science, University of Georgia, Athens 30602.
Vet Parasitol. 1994 Feb;51(3-4):211-7. doi: 10.1016/0304-4017(94)90158-9.
Monensin resistance in a field strain of Eimeria tenella (FS139) was successfully amplified by an in vitro method. Sporozoites of parent FS139, designated as FS139(0), were treated with monensin at 5 micrograms ml-1 before inoculation into chickens. Oocysts developing from these drug-treated sporozoites were designated FS139(5). Sporozoites of FS139(5) were then treated with a higher level of monensin (25 micrograms ml-1), which produced another line called FS139(25). Sporozoites of FS139(25) received a monensin treatment of 100 micrograms ml-1 which yielded line FS139(100). After one passage in chickens, sporozoites of FS139(0), FS139(25) and FS139(100) were treated with either 0, 1, 25, or 100 micrograms ml-1 of monensin and inoculated into chicken primary kidney cell cultures to observe sporozoite invasion rates and development of first generation schizonts. Data on invasion rates and development of schizonts showed that FS139(100) was the most drug-resistant line while FS139(25) was the second most resistant line compared with the parent line FS139(0). These in vitro treatment techniques could be used to develop resistant coccidia for laboratory study of the physiological mechanisms of resistance.
通过体外方法成功扩增了柔嫩艾美耳球虫田间株(FS139)的莫能菌素抗性。将亲本FS139的子孢子(命名为FS139(0))在接种到鸡体内之前用5微克/毫升的莫能菌素处理。从这些经药物处理的子孢子发育而来的卵囊被命名为FS139(5)。然后用更高浓度的莫能菌素(25微克/毫升)处理FS139(5)的子孢子,产生了另一个品系,称为FS139(25)。FS139(25)的子孢子接受100微克/毫升的莫能菌素处理,产生了FS139(100)品系。在鸡体内传代一次后,将FS139(0)、FS139(25)和FS139(100)的子孢子分别用0、1、25或100微克/毫升的莫能菌素处理,并接种到鸡原代肾细胞培养物中,以观察子孢子侵入率和第一代裂殖体的发育情况。关于侵入率和裂殖体发育的数据表明,与亲本品系FS139(0)相比,FS139(100)是耐药性最强的品系,而FS139(25)是耐药性第二强的品系。这些体外处理技术可用于培育耐药球虫,以用于耐药生理机制的实验室研究。